MXPA05007722A - Espuma de fosfato de clindamicina. - Google Patents
Espuma de fosfato de clindamicina.Info
- Publication number
- MXPA05007722A MXPA05007722A MXPA05007722A MXPA05007722A MXPA05007722A MX PA05007722 A MXPA05007722 A MX PA05007722A MX PA05007722 A MXPA05007722 A MX PA05007722A MX PA05007722 A MXPA05007722 A MX PA05007722A MX PA05007722 A MXPA05007722 A MX PA05007722A
- Authority
- MX
- Mexico
- Prior art keywords
- present
- methods
- compositions
- foam
- quick
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/046—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/38—Percompounds, e.g. peracids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/122—Foams; Dry foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dispersion Chemistry (AREA)
- Birds (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Cosmetics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invencion se refiere a varias composiciones de suministro topico farmaceuticamente activas. En particular, las composiciones de la presente invencion estan presentes en un recipiente presurizado que comprende un agente espumante alcoholico de rapida desintegracion , de modo que cuando la composicion se libera, es decir, distribuye, del recipiente presurizado, una espuma sensible a la temperatura de rapida desintegracion se forma. Ademas, la presente invencion proporciona varios aspectos relacionados a tales composiciones, incluyendo metodos para modular una caracteristica de espuma, metodos para mejorar la vida de almacenamiento de un compuesto farmaceuticamente activo, metodos para el tratamiento percutaneo de varias enfermedades, infecciones, y afecciones, y metodos para evaluar las caracteristicas de la espuma.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44228003P | 2003-01-24 | 2003-01-24 | |
US45483203P | 2003-03-13 | 2003-03-13 | |
PCT/AU2004/000088 WO2004064833A1 (en) | 2003-01-24 | 2004-01-23 | Clindamycin phosphate foam |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA05007722A true MXPA05007722A (es) | 2006-01-31 |
Family
ID=32776128
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA05007722A MXPA05007722A (es) | 2003-01-24 | 2004-01-23 | Espuma de fosfato de clindamicina. |
Country Status (16)
Country | Link |
---|---|
US (6) | US7141237B2 (es) |
EP (2) | EP1592420B1 (es) |
JP (2) | JP4828404B2 (es) |
AR (2) | AR042906A1 (es) |
AU (2) | AU2004206769B2 (es) |
BR (1) | BRPI0406905B8 (es) |
CA (1) | CA2513773C (es) |
EA (2) | EA009031B1 (es) |
ES (2) | ES2637956T3 (es) |
IL (2) | IL169761A (es) |
MX (1) | MXPA05007722A (es) |
NO (1) | NO339620B1 (es) |
NZ (1) | NZ541526A (es) |
RS (1) | RS20050557A (es) |
TW (2) | TWI388322B (es) |
WO (1) | WO2004064833A1 (es) |
Families Citing this family (87)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8263580B2 (en) * | 1998-09-11 | 2012-09-11 | Stiefel Research Australia Pty Ltd | Vitamin formulation |
US8512718B2 (en) | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
US20050239675A1 (en) * | 2002-04-01 | 2005-10-27 | Munzer Makansi | Carrier foam to enhance liquid functional performance |
US20050008576A1 (en) * | 2002-04-01 | 2005-01-13 | Munzer Makansi | Carrier foam to enhance liquid functional performance |
US20040043946A1 (en) * | 2002-09-03 | 2004-03-04 | Popp Karl F. | Topical formulations for treatment of skin disorders |
US20040167223A1 (en) * | 2002-09-03 | 2004-08-26 | Popp Karl F. | Topical antibacterial formulations |
US20040171561A1 (en) * | 2002-09-03 | 2004-09-02 | Popp Karl F. | Topical formulations for treatment of rosacea |
IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
US7820145B2 (en) | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
NZ540166A (en) | 2002-10-25 | 2007-06-29 | Foamix Ltd | Cosmetic and pharmaceutical foam |
US7700076B2 (en) * | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
US8119109B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Foamable compositions, kits and methods for hyperhidrosis |
US8119150B2 (en) * | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Non-flammable insecticide composition and uses thereof |
US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US8486376B2 (en) | 2002-10-25 | 2013-07-16 | Foamix Ltd. | Moisturizing foam containing lanolin |
WO2004064833A1 (en) * | 2003-01-24 | 2004-08-05 | Connetics Australia Pty Ltd. | Clindamycin phosphate foam |
US7575739B2 (en) | 2003-04-28 | 2009-08-18 | Foamix Ltd. | Foamable iodine composition |
US7186416B2 (en) * | 2003-05-28 | 2007-03-06 | Stiefel Laboratories, Inc. | Foamable pharmaceutical compositions and methods for treating a disorder |
US8795693B2 (en) * | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
US8486374B2 (en) | 2003-08-04 | 2013-07-16 | Foamix Ltd. | Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses |
AU2004275900B2 (en) | 2003-09-29 | 2010-04-29 | Deb Ip Limited | High alcohol content gel-like and foaming compositions |
US20050123484A1 (en) * | 2003-10-02 | 2005-06-09 | Collegium Pharmaceutical, Inc. | Non-flammable topical anesthetic liquid aerosols |
US20060188449A1 (en) * | 2003-10-03 | 2006-08-24 | Jane Hirsh | Topical aerosol foams |
US8571648B2 (en) * | 2004-05-07 | 2013-10-29 | Aesthera | Apparatus and method to apply substances to tissue |
FR2877842B1 (fr) * | 2004-11-13 | 2008-12-12 | Unilever Nv Naamlooze Vennoots | Produit aerosol anti-transpirant |
DE102004062775A1 (de) | 2004-12-21 | 2006-06-29 | Stockhausen Gmbh | Alkoholischer Pumpschaum |
PL1858323T3 (pl) | 2005-03-07 | 2018-02-28 | Deb Ip Limited | Kompozycje spieniające się o wysokiej zawartości alkoholu, z środkami powierzchniowo czynnymi na bazie silikonu |
AU2006298442A1 (en) | 2005-05-09 | 2007-04-12 | Foamix Ltd. | Saccharide foamable compositions |
PL2526930T3 (pl) * | 2005-06-01 | 2014-05-30 | Glaxosmithkline Ip Dev Ltd | Formulacja witaminowa |
AU2006339311A1 (en) * | 2005-06-07 | 2007-09-07 | Foamix Ltd. | Antibiotic kit and composition and uses thereof |
US20070154402A1 (en) * | 2005-10-24 | 2007-07-05 | Collegium Pharmaceutical, Inc. | Topical Pharmaceutical Foam Composition |
US20070224143A1 (en) * | 2006-03-21 | 2007-09-27 | Kamedis Ltd. | Cosmetic and pharmaceutical foam carrier |
KR101368107B1 (ko) * | 2006-03-31 | 2014-03-14 | 스티펠 리서치 오스트레일리아 피티와이 리미티드 | 발포성 현탁겔 |
WO2008075207A2 (en) * | 2006-04-04 | 2008-06-26 | Foamix Ltd. | Anti-infection augmentation foamable compositions and kit and uses thereof |
US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
FR2910320B1 (fr) | 2006-12-21 | 2009-02-13 | Galderma Res & Dev S N C Snc | Emulsion comprenant au moins un retinoide et du peroxyde de benzole |
FR2910321B1 (fr) | 2006-12-21 | 2009-07-10 | Galderma Res & Dev S N C Snc | Gel creme comprenant au moins un retinoide et du peroxyde de benzole |
US8580860B2 (en) * | 2007-02-23 | 2013-11-12 | Gojo Industries, Inc. | Foamable alcoholic composition |
US20080287373A1 (en) * | 2007-05-17 | 2008-11-20 | Popp Karl F | Topical skin treating kits |
US20090012434A1 (en) * | 2007-07-03 | 2009-01-08 | Anderson Robert S | Apparatus, method, and system to treat a volume of skin |
US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
US20090069795A1 (en) * | 2007-09-10 | 2009-03-12 | Anderson Robert S | Apparatus and method for selective treatment of tissue |
US9439857B2 (en) | 2007-11-30 | 2016-09-13 | Foamix Pharmaceuticals Ltd. | Foam containing benzoyl peroxide |
WO2009090495A2 (en) | 2007-12-07 | 2009-07-23 | Foamix Ltd. | Oil and liquid silicone foamable carriers and formulations |
WO2010041141A2 (en) | 2008-10-07 | 2010-04-15 | Foamix Ltd. | Oil-based foamable carriers and formulations |
AU2009205314A1 (en) | 2008-01-14 | 2009-07-23 | Foamix Ltd. | Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
DE102008006416A1 (de) | 2008-01-28 | 2009-07-30 | Mayer, Thomas, Dr. med. | Clindamycin zur Verwendung bei der Behandlung oder Vorbeugung der bakteriellen Vaginosis |
PT2299810T (pt) | 2008-06-05 | 2020-03-04 | Bausch Health Ireland Ltd | Formulações tópicas farmacológicas que contêm uma baixa concentração de peróxido de benzoilo em suspensão em água e um solvente orgânico miscível em água |
US8119694B2 (en) | 2008-08-15 | 2012-02-21 | Arcion Therapeutics, Inc. | High concentration local anesthetic formulations |
CA2646932A1 (fr) * | 2008-12-10 | 2010-06-10 | Lancelot Biotech Inc. | Methode pour l'application topique d'une formulation medicamenteuse |
EP2395994A4 (en) * | 2009-02-12 | 2013-05-22 | Prec Dermatology Inc | FOAMING COMPOSITIONS OF BENZOYL PEROXIDE FOR TOPICAL ADMINISTRATION |
DK2400951T3 (en) * | 2009-02-25 | 2018-12-03 | Mayne Pharma Llc | TOPICAL FOAM COMPOSITION |
US20120087872A1 (en) | 2009-04-28 | 2012-04-12 | Foamix Ltd. | Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof |
WO2011013008A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
WO2011013009A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
CN102665734A (zh) * | 2009-09-25 | 2012-09-12 | 法马索尔有限公司 | 皮肤用表面涂层 |
US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
EP2482788B1 (en) | 2009-10-02 | 2022-12-14 | Journey Medical Corporation | Topical tetracycline compositions |
CA2794503C (en) * | 2010-03-26 | 2017-11-07 | Precision Dermatology, Inc. | Aerosol foams comprising clindamycin phosphate |
US8968755B2 (en) | 2010-10-23 | 2015-03-03 | Joel Schlessinger | Topical base and active agent-containing compositions, and methods for improving and treating skin |
US8685381B2 (en) | 2010-10-23 | 2014-04-01 | Joel Schlessinger | Topical base and active agent-containing compositions, and methods for improving and treating skin |
FR2969493B1 (fr) * | 2010-12-23 | 2013-07-05 | Galderma Res & Dev | Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant du bpo |
CA2840733A1 (en) * | 2011-06-30 | 2013-01-03 | Allergan, Inc. | Retinoid topical compositions and methods for treating skin conditions |
AU2012292965B2 (en) * | 2011-08-11 | 2015-08-13 | Stiefel Research Australia Pty Ltd | Antioxidant topical compositions |
US8486463B1 (en) | 2012-05-09 | 2013-07-16 | L'oreal | Cosmetic composition comprising aloe vera and caprylyl salicylic acid and method of making |
WO2014011893A1 (en) | 2012-07-11 | 2014-01-16 | Mercy Medical Research Institute | Colorectal delivery device |
WO2014130846A1 (en) | 2013-02-22 | 2014-08-28 | Seungpyo Hong | Transdermal drug delivery using amphiphilic dendron-coil micelles |
JP6740134B2 (ja) * | 2014-03-28 | 2020-08-12 | ガルデルマ・リサーチ・アンド・デヴェロップメント | アダパレン及び過酸化ベンゾイルを含有するすすがない化学ムース剤 |
US9895311B2 (en) | 2014-09-25 | 2018-02-20 | Pharmiva Ab | Foam-forming compositions and methods for delivering an active to a body cavity |
US9265727B1 (en) * | 2015-01-14 | 2016-02-23 | Delcor Asset Corporation | Spray foam corticosteroid product |
WO2017011600A1 (en) | 2015-07-13 | 2017-01-19 | Dr. Reddy's Laboratories, Ltd. | Topical retinoid compositions |
FR3041541B1 (fr) | 2015-09-29 | 2018-11-30 | Galderma Research & Development | Mousse chimique non rincee comprenant de l'ivermectine |
MX2017011630A (es) | 2016-09-08 | 2018-09-25 | Foamix Pharmaceuticals Ltd | Composiciones y metodos para tratar rosacea y acne. |
WO2018129555A1 (en) | 2017-01-09 | 2018-07-12 | Temple University - Of The Commonwealth System Of Higher Education | Methods and compositions for treatment of non-alcoholic steatohepatitis |
AU2018272880B2 (en) | 2017-05-23 | 2024-02-29 | Pharmiva Ab | Foam-forming compositions for delivering an active to a body cavity |
WO2018237218A1 (en) | 2017-06-23 | 2018-12-27 | The Procter & Gamble Company | COMPOSITION AND METHOD FOR ENHANCING SKIN APPEARANCE |
JP2021524505A (ja) * | 2018-05-19 | 2021-09-13 | ゲイリー ビンヤミン, | 発泡体製剤および身体への送達法 |
CN112437657A (zh) | 2018-07-03 | 2021-03-02 | 宝洁公司 | 处理皮肤状况的方法 |
EP4003393A1 (en) | 2019-07-29 | 2022-06-01 | The Board Of Trustees Of The University Of Illinois | Composition and method for promoting wound healing |
US10959933B1 (en) | 2020-06-01 | 2021-03-30 | The Procter & Gamble Company | Low pH skin care composition and methods of using the same |
EP4157206A1 (en) | 2020-06-01 | 2023-04-05 | The Procter & Gamble Company | Method of improving penetration of a vitamin b3 compound into skin |
Family Cites Families (102)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3487068A (en) | 1966-12-16 | 1969-12-30 | Upjohn Co | Lincomycin-2-phosphates,7-substituted compounds and salts thereof |
US3475407A (en) | 1967-12-22 | 1969-10-28 | Upjohn Co | Process for preparing 7(r)- and 7(s)-halolincomycins |
US3544551A (en) | 1968-04-30 | 1970-12-01 | Upjohn Co | 7-mercapto-7-deoxylincomycins and process for preparing the same |
US3509127A (en) | 1968-04-30 | 1970-04-28 | Upjohn Co | Isologs of lincomycins and process for preparing the same |
US3513155A (en) | 1968-05-07 | 1970-05-19 | Upjohn Co | Sulfoxides of 7-halo-7-deoxylincomycins and process |
US3580904A (en) | 1969-04-03 | 1971-05-25 | Upjohn Co | 7-halo-7-deoxy-lincomycin derivatives |
US3714141A (en) | 1970-05-26 | 1973-01-30 | Upjohn Co | Process for making 7-halolincomycins |
US3655885A (en) | 1970-06-10 | 1972-04-11 | Upjohn Co | Antibacterial compositions and methods of treating bacterial infections |
US3969516A (en) | 1974-12-19 | 1976-07-13 | Nelson Research & Development Company | Composition and method for treatment of acne |
JPS5271052A (en) | 1975-12-08 | 1977-06-14 | Tooyoo Daiyamondo Kougiyou Kk | Chain block |
IL52045A (en) * | 1976-08-25 | 1979-12-30 | Mundipharma Ag | Sprayable germicidal foam compositions |
EP0160051B1 (en) | 1983-10-24 | 1992-01-08 | Lockley Services Pty. Ltd. | Foamable biocide composition |
US4568741A (en) | 1984-05-15 | 1986-02-04 | The Upjohn Company | Synthesis of 7-halo-7-deoxylincomycins |
EP0190158A1 (en) | 1984-06-21 | 1986-08-13 | Soltec Research Pty. Ltd. | Aerosol product |
CN1004002B (zh) | 1984-11-29 | 1989-04-26 | 厄普约翰公司 | 制备7-卤-7-去氧林可霉素及其类似化合物的改进方法 |
US4806262A (en) | 1985-08-14 | 1989-02-21 | The Procter & Gamble Company | Nonlathering cleansing mousse with skin conditioning benefits |
US5446028A (en) * | 1985-12-12 | 1995-08-29 | Dermik Laboratories, Inc. | Anti-acne method and composition |
US4882182A (en) | 1987-01-08 | 1989-11-21 | Soltec Research Pty. Ltd. | Aerosol product |
US4920101A (en) | 1987-09-30 | 1990-04-24 | Nelson Research & Development Co. | Compositions comprising 1-oxo- or thiohydrocarbyl substituted azacycloaklkanes |
AU619256B2 (en) | 1988-03-03 | 1992-01-23 | Connetics Australia Pty Ltd | Acne treatment |
DK0414920T3 (da) | 1989-03-17 | 1997-12-15 | Taisho Pharmaceutical Co Ltd | Aerosolpræparater til udvortes brug |
EP0484530B1 (en) | 1989-07-28 | 1995-07-12 | Hisamitsu Pharmaceutical Co., Inc. | Foamed aerosol preparation |
US5935554A (en) | 1990-09-03 | 1999-08-10 | Soltec Research Pty. Ltd. | Concentrated aerosol space spray that is not an emulsion |
JP3140460B2 (ja) | 1990-09-03 | 2001-03-05 | ソルテック リサーチ プロプライアタリィ リミティド | 濃縮したエーロゾルスペーススプレー |
GB9111477D0 (en) * | 1991-05-29 | 1991-07-17 | Sandoz Ltd | Pharmaceutical composition |
FR2677369B1 (fr) * | 1991-06-05 | 1994-09-16 | Promotion Rech Innovation Tec | Mousse aerosol. |
JPH05271052A (ja) * | 1992-03-26 | 1993-10-19 | Dotsuto:Kk | 尋常性ザ瘡治療用ローション |
US5635469A (en) * | 1993-06-10 | 1997-06-03 | The Procter & Gamble Company | Foaming cleansing products |
RU2134101C1 (ru) * | 1993-07-01 | 1999-08-10 | Яманаухи Эуропе Б.В. | Стабильные местнодействующие ретиноидные композиции |
US5466446A (en) * | 1994-02-16 | 1995-11-14 | Stiefel Laboratories, Inc. | Topical compositions containing bensoyl peroxide and clindamycin and method of use thereof |
FR2722098B1 (fr) | 1994-07-06 | 1996-08-23 | Cird Galderma | Nouveaux medicaments a base de metro-nidazole ou d'un melange synergetique de metronidazole et de clindamycine |
US5679324A (en) * | 1994-07-08 | 1997-10-21 | The Procter & Gamble Co. | Aerosol foamable fragrance composition |
US5776430A (en) | 1994-11-01 | 1998-07-07 | Calgon Vestal, Inc. | Topical antimicrobial cleanser containing chlorhexidine gluconate and alcohol |
GB9504265D0 (en) * | 1995-03-03 | 1995-04-19 | Medeva Plc | Corticosteroid-containing pharmaceutical composition |
US5783202A (en) * | 1995-03-14 | 1998-07-21 | Soltec Research Pty. Ltd. | Pediculicidal mousse composition for killing head lice |
FR2740685B1 (fr) | 1995-11-08 | 1998-01-23 | Pf Medicament | Composition pharmaceutique topique moussante pour le traitement des dermatoses, induites par pityrosporum ovale |
US5788155A (en) | 1996-06-28 | 1998-08-04 | S. C. Johnson & Son, Inc. | Air freshener dispenser device with dual cartridge capacity |
AUPO379596A0 (en) | 1996-11-22 | 1996-12-19 | Soltec Research Pty Ltd | Percutaneous delivery system |
US5843881A (en) * | 1997-02-13 | 1998-12-01 | The Procter & Gamble Company | Spray compositions |
AUPO688997A0 (en) | 1997-05-20 | 1997-06-12 | Soltec Research Pty Ltd | Sunscreen composition |
AUPO983897A0 (en) * | 1997-10-17 | 1997-11-06 | Soltec Research Pty Ltd | Topical antifungal composition |
WO1999038521A1 (de) * | 1998-02-02 | 1999-08-05 | Boehringer Ingelheim Vetmedica Gmbh | Verwendung von wirkstoffkombinationen aus antimikrobiell wirkenden substanzen und terpenhaltigen pflanzenextrakten in der tiermedizin |
US6231875B1 (en) | 1998-03-31 | 2001-05-15 | Johnson & Johnson Consumer Companies, Inc. | Acidified composition for topical treatment of nail and skin conditions |
AUPP310798A0 (en) | 1998-04-22 | 1998-05-14 | Soltec Research Pty Ltd | Vehicle system for a composition comprising a piperidinopyrimidine derivative |
AU760065B2 (en) * | 1998-04-27 | 2003-05-08 | Larex, Inc. | Derivatives of arabinogalactan and compositions including the same |
US6013637A (en) * | 1998-06-12 | 2000-01-11 | Dermik Laboratories Inc. | Anti-acne method and composition |
US6284234B1 (en) | 1998-08-04 | 2001-09-04 | Johnson & Johnson Consumer Companies, Inc. | Topical delivery systems for active agents |
US8263580B2 (en) * | 1998-09-11 | 2012-09-11 | Stiefel Research Australia Pty Ltd | Vitamin formulation |
AUPP583198A0 (en) * | 1998-09-11 | 1998-10-01 | Soltec Research Pty Ltd | Mousse composition |
DE19855097A1 (de) * | 1998-11-28 | 2000-05-31 | Wella Ag | Pigmenthaltiges, verschäumbares Gel |
US7115277B2 (en) * | 1999-03-04 | 2006-10-03 | Allergan, Inc. | Method for enabling delivery of an active agent |
US6383471B1 (en) | 1999-04-06 | 2002-05-07 | Lipocine, Inc. | Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents |
US20030003170A1 (en) * | 2000-06-02 | 2003-01-02 | Theresa Callaghan | Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium) |
US6358541B1 (en) * | 2000-05-03 | 2002-03-19 | David S. Goodman | Topical preparation for the treatment of hair loss |
US6387383B1 (en) | 2000-08-03 | 2002-05-14 | Dow Pharmaceutical Sciences | Topical low-viscosity gel composition |
US6428772B1 (en) * | 2001-06-25 | 2002-08-06 | Blistex Inc. | Acne treatment composition with cooling effect |
WO2003009559A1 (fr) | 2001-07-16 | 2003-01-30 | Fujitsu Limited | Unite peripherique |
HU0104790D0 (en) * | 2001-11-08 | 2002-01-28 | Human Rt | Pharmaceutical combinations for topical application |
FR2832311B1 (fr) * | 2001-11-21 | 2004-04-16 | Besins Int Belgique | Poudre filmogene, compositions la comprenant, leurs procedes de preparation et leurs utilisations |
US20040043946A1 (en) * | 2002-09-03 | 2004-03-04 | Popp Karl F. | Topical formulations for treatment of skin disorders |
US9668972B2 (en) * | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
US7820145B2 (en) * | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
US20050205086A1 (en) * | 2002-10-25 | 2005-09-22 | Foamix Ltd. | Retinoid immunomodulating kit and composition and uses thereof |
NZ540166A (en) * | 2002-10-25 | 2007-06-29 | Foamix Ltd | Cosmetic and pharmaceutical foam |
US7704518B2 (en) * | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
US20080031907A1 (en) * | 2002-10-25 | 2008-02-07 | Foamix Ltd. | Cosmetic and pharmaceutical foam |
US9265725B2 (en) * | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US20060193789A1 (en) * | 2002-10-25 | 2006-08-31 | Foamix Ltd. | Film forming foamable composition |
US7700076B2 (en) * | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
US20070292461A1 (en) * | 2003-08-04 | 2007-12-20 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
WO2004064833A1 (en) * | 2003-01-24 | 2004-08-05 | Connetics Australia Pty Ltd. | Clindamycin phosphate foam |
DE50304744D1 (de) * | 2003-04-28 | 2006-10-05 | Biofrontera Bioscience Gmbh | Verwendung von Riluzole kombiniert mit geeigneten Hilfs-und Zusatzstoffen zur Behandlung von Krankheiten, die durch eine Hyperproliferation von Keratinozyten gekennzeichnet sind, insbesondere Neurodermitis und Psoriasis |
US20050014729A1 (en) * | 2003-07-16 | 2005-01-20 | Pharmacia Corporation | Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith |
EP1670435A2 (en) * | 2003-08-04 | 2006-06-21 | Foamix Ltd. | Foam carrier containing amphiphilic copolymeric gelling agent |
US8486374B2 (en) * | 2003-08-04 | 2013-07-16 | Foamix Ltd. | Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses |
EP1663148A2 (en) * | 2003-08-25 | 2006-06-07 | Foamix Ltd. | Penetrating pharmaceutical foam |
ITMI20032019A1 (it) * | 2003-10-17 | 2005-04-18 | Fidia Farmaceutici | Microemulsioni di retinoidi e composizioni farmaceutiche che le contengono |
US20050191343A1 (en) * | 2003-11-26 | 2005-09-01 | Shire Laboratories, Inc. | Micellar systems useful for delivery of lipophilic or hydrophobic compounds |
WO2005079775A1 (en) * | 2004-02-13 | 2005-09-01 | Pcr Technology Holdings, Lc | Method and preparation for reducing irritation and/or inflammatory reaction in human skin |
US20050238597A1 (en) * | 2004-04-26 | 2005-10-27 | Mccook John P | Topical treatment of acne, seborrheic dermatitis, and oily skin with formulations containing histamine antagonists |
US20070196323A1 (en) * | 2004-06-07 | 2007-08-23 | Jie Zhang | Polyvinyl alcohol-containing compositions and methods for dermal delivery of drugs |
US20070189977A1 (en) * | 2004-06-07 | 2007-08-16 | Jie Zhang | Spray-on formulations and methods for dermal delivery of drugs |
US8907153B2 (en) * | 2004-06-07 | 2014-12-09 | Nuvo Research Inc. | Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same |
US20070196453A1 (en) * | 2004-06-07 | 2007-08-23 | Jie Zhang | Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs |
BRPI0514806A (pt) * | 2004-08-31 | 2008-06-24 | Connetics Australia Pty Ltd | composições e processo de microemulsão e emulsão sub-mìcron |
WO2006040644A2 (en) | 2004-10-11 | 2006-04-20 | Ranbaxy Laboratories Limited | Processes for the preparation of substituted thiochroman derivatives |
TW200711649A (en) * | 2005-06-17 | 2007-04-01 | Combinatorx Inc | Combination therapy for the treatment of immunoinflammatory disorders |
US9393218B2 (en) * | 2005-12-23 | 2016-07-19 | Epinamics Gmbh | Use of film-forming hair care polymers from the group of polyurethanes and pharmaceutical preparations and patches that contain these polymers |
RU2437680C2 (ru) | 2005-12-23 | 2011-12-27 | Эпинамикс ГмбХ | Применение формирующих пленки полимеров из группы полиуретанов для ухода за волосами и фармацевтические препараты, содержащие эти полимеры |
WO2007082864A2 (en) | 2006-01-20 | 2007-07-26 | Polichem Sa | Use of chavicol as an antiseptic |
US7252816B1 (en) * | 2006-03-29 | 2007-08-07 | Dow Pharmaceutical Sciences | Topical acne vulgairs medication with a sunscreen |
KR101368107B1 (ko) * | 2006-03-31 | 2014-03-14 | 스티펠 리서치 오스트레일리아 피티와이 리미티드 | 발포성 현탁겔 |
WO2008075207A2 (en) | 2006-04-04 | 2008-06-26 | Foamix Ltd. | Anti-infection augmentation foamable compositions and kit and uses thereof |
US20070280972A1 (en) * | 2006-04-25 | 2007-12-06 | Zars, Inc. | Adhesive solid gel-forming formulations for dermal drug delivery |
MXPA06008988A (es) | 2006-08-08 | 2008-02-07 | Fernando Ahumada Ayala | Preparaciones topicas antiacne que contienen retinoide (tazaroteno o adapaleno), antibiotico (fosfato de clindamicina) y/o queratolitico (peroxido de bonzoilo en microesponjas). |
EP2089017A2 (en) | 2006-11-02 | 2009-08-19 | Aestus Therapeutics, Inc. | Methods of treating neuropathic pain by modulation of glycogenolysis or glycolysis pathways |
AU2007355106A1 (en) | 2006-11-29 | 2008-12-18 | Foamix Ltd. | Foamable waterless compositions with modulating agents |
EP1958613A1 (en) | 2007-02-15 | 2008-08-20 | Polichem S.A. | Dermal film-forming liquid formulations for drug release to skin |
DE102007059704A1 (de) | 2007-02-28 | 2008-09-04 | Henkel Ag & Co. Kgaa | Reinigende O/W-Emulsion |
DE102007059703A1 (de) | 2007-02-28 | 2008-09-04 | Henkel Ag & Co. Kgaa | Wirkstoff-stabiliserte O/W-Emulsionen II |
FR2915682B1 (fr) | 2007-05-04 | 2009-07-03 | Galderma Res & Dev | Compositions depigmentantes dermatologiques et cosmetiques, leurs procedes de preparation, et leurs utilisations |
JP5946990B2 (ja) | 2007-08-29 | 2016-07-06 | エージェンシー フォー サイエンス,テクノロジー アンド リサーチ | 化粧品及び医薬品使用のための精油を含有する糖系界面活性剤マイクロエマルジョン |
-
2004
- 2004-01-23 WO PCT/AU2004/000088 patent/WO2004064833A1/en active Search and Examination
- 2004-01-23 CA CA2513773A patent/CA2513773C/en not_active Expired - Lifetime
- 2004-01-23 JP JP2006500417A patent/JP4828404B2/ja not_active Expired - Lifetime
- 2004-01-23 BR BRPI0406905A patent/BRPI0406905B8/pt active IP Right Grant
- 2004-01-23 EA EA200501169A patent/EA009031B1/ru not_active IP Right Cessation
- 2004-01-23 AU AU2004206769A patent/AU2004206769B2/en not_active Expired
- 2004-01-23 RS YUP-2005/0557A patent/RS20050557A/sr unknown
- 2004-01-23 AR ARP040100187A patent/AR042906A1/es not_active Application Discontinuation
- 2004-01-23 ES ES10158720.2T patent/ES2637956T3/es not_active Expired - Lifetime
- 2004-01-23 EP EP04704507.5A patent/EP1592420B1/en not_active Expired - Lifetime
- 2004-01-23 US US10/763,379 patent/US7141237B2/en not_active Expired - Lifetime
- 2004-01-23 ES ES04704507.5T patent/ES2450133T3/es not_active Expired - Lifetime
- 2004-01-23 EA EA200701259A patent/EA014372B1/ru not_active IP Right Cessation
- 2004-01-23 MX MXPA05007722A patent/MXPA05007722A/es active IP Right Grant
- 2004-01-23 NZ NZ541526A patent/NZ541526A/en not_active IP Right Cessation
- 2004-01-23 EP EP10158720.2A patent/EP2289512B8/en not_active Expired - Lifetime
- 2004-01-27 TW TW099113101A patent/TWI388322B/zh not_active IP Right Cessation
- 2004-01-27 TW TW093101716A patent/TWI355267B/zh not_active IP Right Cessation
-
2005
- 2005-07-19 IL IL169761A patent/IL169761A/en active IP Right Grant
- 2005-07-22 NO NO20053577A patent/NO339620B1/no not_active IP Right Cessation
-
2006
- 2006-02-07 US US11/349,820 patent/US7749488B2/en not_active Expired - Lifetime
- 2006-08-09 US US11/463,573 patent/US7374747B2/en not_active Expired - Lifetime
-
2009
- 2009-11-10 AU AU2009235974A patent/AU2009235974B2/en not_active Expired
-
2010
- 2010-05-20 US US12/783,824 patent/US20100266511A1/en not_active Abandoned
-
2011
- 2011-06-10 JP JP2011130433A patent/JP5480201B2/ja not_active Expired - Lifetime
- 2011-07-14 IL IL214118A patent/IL214118A/en active IP Right Grant
- 2011-08-01 AR ARP110102768A patent/AR082432A2/es not_active Application Discontinuation
- 2011-11-30 US US13/307,533 patent/US8586008B2/en not_active Expired - Lifetime
-
2013
- 2013-10-14 US US14/053,085 patent/US9486394B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200420303A (en) | Clindamycin phosphate foam | |
TW200616650A (en) | Semi-solid delivery vehicle and pharmaceutical compositions | |
WO2008152444A3 (en) | Foamable waterless compositions with modulating agents | |
WO2005041925A3 (en) | Compositions and dosage forms for enhanced absorption | |
WO2005112633A3 (en) | Compounds and compositions for delivering active agents | |
WO2008057802A3 (en) | Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same | |
UA96965C2 (ru) | ЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ 2,3-ДИГИДРОИМИДАЗО[1,2-с]ХИНАЗОЛИНА, ПОЛЕЗНЫЕ ДЛЯ ЛЕЧЕНИЯ ГИПЕРПРОЛИФЕРАТИВНЫХ НАРУШЕНИЙ И БОЛЕЗНЕЙ, СВЯЗАННЫХ С АНГИОГЕНЕЗОМ | |
WO2007022061A3 (en) | Formulations and methods for providing progestin-only contraception while minimizing adverse side effects associated therewith | |
WO2007067520A3 (en) | Lipid-based compositions of antiinfectives for treating pulmonary infections | |
WO2007090822A3 (de) | Pharmazeutische formulierung für aerosole mit zwei oder mehr wirkstoffen und mindestens einer oberflächenaktiven substanz | |
WO2009087578A3 (en) | Sensation modifying topical composition foam | |
MY143795A (en) | Tetrahydropyridoindole derivatives | |
ATE391708T1 (de) | Verbindungen und gemische zur verabreichung eines aktiven agens | |
NZ548178A (en) | Topical formulations comprising a 1-N-arylpyrazole derivative and a formamidine | |
WO2007060108A3 (de) | Aerosolformulierung für die inhalation enthaltend ein anticholinergikum | |
DK1392328T3 (da) | Medikament til beskyttelse i radioterapi | |
WO2007133751A3 (en) | Base-stabilized polyorthoester formulations | |
CA2494473A1 (en) | Stabilized protein compositions for topical administration and methods of making same | |
WO2002070464A3 (en) | Hydrazones and their therapeutic use | |
UA87312C2 (ru) | КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ | |
WO2002036129A3 (de) | Topische behandlung von mastalgie mit aromatase-hemmern, wie androstendion | |
RS88404A (en) | Low dose liquid entecavir formulation and use | |
WO2003035080A3 (en) | A process for the preparation of pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors | |
WO2006021401A3 (en) | Bicylononene derivatives | |
AU2001261516A1 (en) | Semi-solid delivery vehicle and pharmaceutical compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
HC | Change of company name or juridical status |